Indonesia approves first homegrown COVID-19 vaccine | Inquirer News

Indonesia approves first homegrown COVID-19 vaccine

/ 02:19 PM September 30, 2022

Indonesia has approved its first locally developed COVID-19 vaccine for emergency use

FILE PHOTO: A health worker administers a dose of the Sinovac COVID-19 vaccine at a convention hall building in Banda Aceh on July 26, 2021. (Photo by CHAIDEER MAHYUDDIN / AFP)

JAKARTA — Indonesia has approved its first locally developed COVID-19 vaccine for emergency use, the head of the country’s public health agency said Friday, hailing it as a step toward “the nation’s independence in access to medicine.”

Jakarta has stressed the importance of developing national vaccines since the beginning of the pandemic but it currently relies on China’s Sinovac and the Western-made Moderna and Pfizer-BioNTech mRNA jabs.

ADVERTISEMENT

The IndoVac jab, developed by state-owned pharmaceutical company Bio Farma and Texas-based Baylor College of Medicine, can now be used as a primary dose for an unvaccinated or partially vaccinated adult in the world’s fourth most-populous country.

FEATURED STORIES

“The development… of a domestic vaccine is a pride for us Indonesians as a foundation and as the first step to achieve the nation’s independence in access to medicine,” head of the national food and drugs agency (BPOM) Penny Lukito said at a press conference Friday.

The medical chief said IndoVac had shown an efficacy rate of 92 percent, while there were no reports of death linked to it in trials and reported side effects were “generally mild”.

A clinical study to use it as a booster jab is underway, Lukito said.

The agency also announced it had granted emergency use approval for an mRNA vaccine developed in China, becoming the first country to do so.

The inoculation developed by Walvax Biotechnology will be locally produced in Indonesia, the BPOM chief said.

The homegrown IndoVac jab has been granted a halal certificate, meaning it can be administered in line with the Islamic faith in Muslim-majority Indonesia.

ADVERTISEMENT

Indonesia became the epicenter of Asia’s COVID-19 pandemic in July last year as the Delta variant swept through the country.

Daily cases declined significantly by the end of the year but the spread of Omicron brought confirmed cases back to 30,000 a day.

It has since seen another sharp fall in case numbers and eliminated quarantine requirements for vaccinated travelers.

In total, Southeast Asia’s largest economy has reported over 6.4 million confirmed cases with nearly 160,000 deaths.

Vaccination rollout has also been relatively slow compared to developed nations, with less than two-thirds of the population of 270 million receiving two jabs.

RELATED STORY

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Latest COVID wave: When waning immunity, expired vaccines, new strains mix

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Health, Indonesia, Vaccines, Virus

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.